Moderna price forecast: Stephen Weiss sees upside

Shares of Moderna Inc (NASDAQ: MRNA) are down more than 15% since Thursday when Merck said its oral COVID-19 pill reduces the risk of hospitalization and death by 50%. But Short Hills Capital Partners’ Stephen Weiss is convinced the sell-off is only transitory. Weiss’ remarks on CNBC’s “Halftime Report” Weiss continues to see the dip […]